China Biopharma IPOs Skyrocket In 2010 After Freeze Is Lifted
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The number of initial public offerings by pharmaceutical and biotech companies in China continued to rise in 2010, continuing a surge in IPOs that started in mid-2009
You may also be interested in...
India Draws Lessons From China To Help Foster Biotech Industry
India's Ministry of Science and Technology is exploring ways to spark innovation, from luring Indian scientists back from abroad to easing the path for government funding – PharmAsia News takes a closer look.
Fidelity Growth Partner Asia's Norman Chen On Being An Active Investor In China: An Interview With PharmAsia News (Part 2 of 2)
Fidelity Growth Partners Asia has made its name on several blockbuster investments in China. In the IT sector, Fidelity invested in Alibaba, China's leading e-commerce company. In healthcare, Fidelity was an early investor in China's leading CRO WuXi AppTec Inc. and remains one of its largest shareholders.
Fidelity Growth Partner Asia's Norman Chen On Being An Active Investor In China: An Interview With PharmAsia News (Part 2 of 2)
Fidelity Growth Partners Asia has made its name on several blockbuster investments in China. In the IT sector, Fidelity invested in Alibaba, China's leading e-commerce company. In healthcare, Fidelity was an early investor in China's leading CRO WuXi AppTec Inc. and remains one of its largest shareholders.